Cerenome CNSY
NASDAQ CNSY
$1.60 -0.18 (-10.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cerenome (CNSY) Liabilities from Discontinued Operations (2018 - 2019)

Updated

Cerenome (CNSY) reported Liabilities from Discontinued Operations of $2.1 million for Q2 2019.

Analysis

Cerenome (CNSY) Liabilities from Discontinued Operations (2018 - 2019) Analysis & Trends

At the end of FY2018, Cerenome posted Liabilities from Discontinued Operations of $245,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Cerenome 11.70 Mn -35.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 2.10 Mn
Dec 31, 2018 245,000.00
API Access

Cerenome Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=CNSY&period=max&api_key=YOUR_API_KEY